Brief: Alphamab Oncology Says Aware Of Certain Media Reports
24/11/2023 12:38
Nov 24 (Reuters) - Alphamab Oncology 9966.HK :
* BEEN MADE AWARE OF CERTAIN MEDIA REPORTS CLAIMING INSIDE
INFORMATION REGARDING CLINICAL UPDATES WAS RELEASED PRIOR TO
DISCLOSURE
* HAS TAKEN STEPS IN RESPONSE TO UNUSUAL PRICE MOVEMENTS AND
MEDIA
REPORTS INCLUDING COMMUNICATING WITH COMPETENT AUTHORITY
PROMPTLY
Source text for Eikon: ID:nHKS2FjHfy
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)